Russia's Sputnik V, Sputnik Light coronavirus vaccines authorized for use in Cambodia - RDIF

Interfax, 31.10.2021

MOSCOW. Oct 31 (Interfax) - The Russian-designed coronavirus vaccines Sputnik V and Sputnik Light have been authorized for use in Cambodia under the emergency use procedure, the Russian Direct Investment Fund (RDIF) said.

"Cambodia has become the 71st country in the world to register the Russian vaccine. Sputnik V was granted an emergency use authorization," RDIF said in a statement on its website on Sunday.

"The Russian vaccine ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators," it said.

"The one-shot Sputnik Light vaccine is based on the human adenovirus serotype 26, the first component of Sputnik V.," it said.

After the vaccine was authorized for use in Russia on May 6, 2021, it was granted authorization in Angola, Armenia, Bahrein, Belarus, Venezuela, Egypt, Iran, Kazakhstan, Congo, Kyrgyzstan, Mauritius, Mongolia, Nicaragua, UAE, Palestine and the Philippines. Bahrein has begun using Sputnik Light alongside the Pfizer/Biontech vaccine as a booster dose for vaccinated people. The vaccine is currently in the process of registration in another 30 countries, RDIF said.